Published in J Clin Invest on February 01, 2005
Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest (2006) 2.04
Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res (2010) 2.00
Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler Thromb Vasc Biol (2008) 1.98
Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng Part B Rev (2010) 1.76
Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arterioscler Thromb Vasc Biol (2008) 1.62
Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am J Physiol Cell Physiol (2008) 1.46
Bone morphogenetic protein-induced MSX1 and MSX2 inhibit myocardin-dependent smooth muscle gene transcription. Mol Cell Biol (2006) 1.36
Transforming growth factor-beta1 (TGF-beta1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells. J Biol Chem (2011) 1.35
Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol (2011) 1.34
Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol (2009) 1.32
Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1. Mol Cell Biol (2005) 1.25
NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor. Free Radic Biol Med (2010) 1.18
Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts. J Biol Chem (2011) 1.13
PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns. Am J Physiol Heart Circ Physiol (2008) 1.12
PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins. Mol Cell Biol (2005) 1.09
Myocardin in biology and disease. J Biomed Res (2014) 1.06
The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin. J Biol Chem (2009) 1.06
Smooth and cardiac muscle-selective knock-out of Kruppel-like factor 4 causes postnatal death and growth retardation. J Biol Chem (2010) 1.06
CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation. Mol Cell Biol (2009) 1.05
The four-and-a-half LIM domain protein 2 regulates vascular smooth muscle phenotype and vascular tone. J Biol Chem (2009) 1.01
Transforming growth factor-β1-induced transcript 1 protein, a novel marker for smooth muscle contractile phenotype, is regulated by serum response factor/myocardin protein. J Biol Chem (2011) 1.01
Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching in vivo. Circ Res (2012) 1.01
Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin. J Biol Chem (2012) 1.00
Extracellular matrix synthesis in vascular disease: hypertension, and atherosclerosis. J Biomed Res (2013) 0.93
Modulation of myocardin function by the ubiquitin E3 ligase UBR5. J Biol Chem (2010) 0.93
Defining smooth muscle cells and smooth muscle injury. J Clin Invest (2005) 0.92
Chromatin immunoprecipitation (ChIP): revisiting the efficacy of sample preparation, sonication, quantification of sheared DNA, and analysis via PCR. PLoS One (2011) 0.91
Sm22α transcription occurs at the early onset of the cardiovascular system and the intron 1 is dispensable for its transcription in smooth muscle cells during mouse development. Int J Physiol Pathophysiol Pharmacol (2009) 0.87
Characterization of zebrafish intestinal smooth muscle development using a novel sm22α-b promoter. Dev Dyn (2010) 0.86
Maintenance of radiation-induced intestinal fibrosis: cellular and molecular features. World J Gastroenterol (2007) 0.84
Development of viral vectors for use in cardiovascular gene therapy. Viruses (2010) 0.81
Intronic CArG box regulates cysteine-rich protein 2 expression in the adult but not in developing vasculature. Arterioscler Thromb Vasc Biol (2010) 0.80
Vascular smooth muscle cell differentiation-2010. J Biomed Res (2010) 0.79
Myocardin regulates vascular smooth muscle cell inflammatory activation and disease. Arterioscler Thromb Vasc Biol (2015) 0.79
Myocardin: new therapeutic agent in vascular disease? Arterioscler Thromb Vasc Biol (2013) 0.78
Characteristics of the CArG-SRF binding context in mammalian genomes. Mamm Genome (2009) 0.76
A New Editor of Smooth Muscle Phenotype. Circ Res (2016) 0.75
Genome-wide microarray analyses identify the protein C receptor as a novel calcineurin/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation. Arterioscler Thromb Vasc Biol (2011) 0.75
Differentiated Smooth Muscle Cells Generate a Subpopulation of Resident Vascular Progenitor Cells in the Adventitia Regulated by KLF4. Circ Res (2016) 0.75
Set7 mediated interactions regulate transcriptional networks in embryonic stem cells. Nucleic Acids Res (2016) 0.75
Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev (2004) 16.52
Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell (2001) 8.09
Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell (2003) 7.43
Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol (2002) 4.92
Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol (2003) 4.51
Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci. EMBO J (2001) 4.28
Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res (2003) 3.99
Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci U S A (2002) 3.74
Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol (2003) 3.69
Human and Drosophila homeodomain proteins that enhance the DNA-binding activity of serum response factor. Science (1992) 2.99
Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol (1996) 2.88
Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol (2003) 2.73
The serum response element. Trends Biochem Sci (1992) 2.61
Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J Biol Chem (2000) 2.54
Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest (2000) 2.33
Integration and stable germ line transmission of genes injected into mouse pronuclei. Science (1981) 2.31
Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem (2001) 2.28
Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. Circ Res (1999) 2.20
Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells. J Biol Chem (2004) 1.98
Actin and tropomyosin variants in smooth muscles. Dependence on tissue type. J Biol Chem (1984) 1.92
A transforming growth factor-beta control element required for SM alpha-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression. J Biol Chem (2003) 1.90
Point mutational analysis of the human c-fos serum response factor binding site. Nucleic Acids Res (1989) 1.76
Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation (1996) 1.70
CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest (2001) 1.69
SRF and MCM1 have related but distinct DNA binding specificities. Nucleic Acids Res (1992) 1.67
MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo. J Biol Chem (1999) 1.58
Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Dev Biol (1992) 1.49
BTEB2, a Krüppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circ Res (1999) 1.40
Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol (1997) 1.37
Interaction of CArG elements and a GC-rich repressor element in transcriptional regulation of the smooth muscle myosin heavy chain gene in vascular smooth muscle cells. J Biol Chem (1997) 1.36
Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol (1996) 1.34
The smooth muscle alpha-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells. J Biol Chem (1995) 1.29
Muscle specificity encoded by specific serum response factor-binding sites. J Biol Chem (2001) 1.27
Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor. J Biol Chem (2000) 1.26
The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. Am J Respir Cell Mol Biol (2003) 1.24
Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res (2001) 1.22
Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox. Circ Res (1997) 1.16
Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin. Circ Res (2004) 1.15
Stretch-induced alternative splicing of serum response factor promotes bronchial myogenesis and is defective in lung hypoplasia. J Clin Invest (2000) 1.14
Smooth muscle alpha-actin gene requires two E-boxes for proper expression in vivo and is a target of class I basic helix-loop-helix proteins. Circ Res (2003) 1.13
Natural and synthetic DNA elements with the CArG motif differ in expression and protein-binding properties. Mol Cell Biol (1991) 1.08
Serum response factor is modulated by the SUMO-1 conjugation system. Biochem Biophys Res Commun (2003) 1.03
Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells. J Biol Chem (2001) 1.03
Increased expression of alternatively spliced dominant-negative isoform of SRF in human failing hearts. Am J Physiol Heart Circ Physiol (2002) 0.99
Four isoforms of serum response factor that increase or inhibit smooth-muscle-specific promoter activity. Biochem J (2000) 0.99
Lost in transdifferentiation. J Clin Invest (2004) 0.98
A competitive mechanism of CArG element regulation by YY1 and SRF: implications for assessment of Phox1/MHox transcription factor interactions at CArG elements. DNA Cell Biol (1997) 0.90
Endothelial cell-conditioned medium downregulates smooth muscle contractile protein expression. Am J Physiol (1997) 0.80
Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev (2004) 16.52
Increased methylation variation in epigenetic domains across cancer types. Nat Genet (2011) 8.92
Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res (2003) 3.99
Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol (2003) 3.69
A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant (2011) 3.49
Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation (2005) 3.12
Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem (2004) 2.94
Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res (2007) 2.55
Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res (2005) 2.45
Molecular determinants of vascular smooth muscle cell diversity. Circ Res (2005) 2.33
Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res (2008) 2.30
Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res (2012) 2.28
Smooth muscle cell plasticity: fact or fiction? Circ Res (2012) 2.18
Forced expression of myocardin is not sufficient for induction of smooth muscle differentiation in multipotential embryonic cells. Arterioscler Thromb Vasc Biol (2004) 2.09
Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res (2010) 2.04
Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest (2006) 2.04
Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ Res (2007) 2.00
Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol (2011) 1.98
Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol (2012) 1.94
Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol (2004) 1.93
Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase. Proc Natl Acad Sci U S A (2006) 1.91
Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol (2006) 1.91
A transforming growth factor-beta control element required for SM alpha-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression. J Biol Chem (2003) 1.90
Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells (2006) 1.80
Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res (2009) 1.78
Angiotensin II, focal adhesion kinase, and PRX1 enhance smooth muscle expression of lipoma preferred partner and its newly identified binding partner palladin to promote cell migration. Circ Res (2007) 1.76
Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest (2011) 1.70
Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol Cell Physiol (2007) 1.70
Excitation-transcription coupling in arterial smooth muscle. Circ Res (2006) 1.70
Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy. J Mol Cell Cardiol (2011) 1.69
PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol Cell Biol (2006) 1.65
Programming smooth muscle plasticity with chromatin dynamics. Circ Res (2007) 1.63
Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia. Proc Jpn Acad Ser B Phys Biol Sci (2008) 1.60
Heme oxygenase and heme degradation. Biochem Biophys Res Commun (2005) 1.57
Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg (2009) 1.53
Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension (2005) 1.49
Catalytic mechanism of heme oxygenase through EPR and ENDOR of cryoreduced oxy-heme oxygenase and its Asp 140 mutants. J Am Chem Soc (2002) 1.48
Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am J Physiol Cell Physiol (2008) 1.46
Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods (2013) 1.46
Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. Am J Physiol Cell Physiol (2006) 1.44
Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol (2003) 1.42
Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am J Physiol Heart Circ Physiol (2004) 1.40
Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol (2008) 1.37
Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol (2009) 1.32
Crystal structure of the dioxygen-bound heme oxygenase from Corynebacterium diphtheriae: implications for heme oxygenase function. J Biol Chem (2004) 1.31
Assessment of contractility of purified smooth muscle cells derived from embryonic stem cells. Stem Cells (2006) 1.29
Discovery, biological evaluation, and structure-activity relationship of amidine based sphingosine kinase inhibitors. J Med Chem (2010) 1.28
Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res (2009) 1.23
Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2013) 1.23
Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead. Indian J Med Res (2013) 1.21
Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochem Biophys Res Commun (2006) 1.20
Focused in vivo delivery of plasmid DNA to the porcine vascular wall via intravascular ultrasound destruction of microbubbles. J Vasc Res (2009) 1.19
Origin of neointimal smooth muscle: we've come full circle. Arterioscler Thromb Vasc Biol (2006) 1.17
Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5). Am J Physiol Cell Physiol (2011) 1.15
Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol (2008) 1.15
Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin. Circ Res (2004) 1.15
Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor. Mol Cancer Ther (2007) 1.15
The crystal structures of the ferric and ferrous forms of the heme complex of HmuO, a heme oxygenase of Corynebacterium diphtheriae. J Biol Chem (2003) 1.15
Critical role of TNF-α in cerebral aneurysm formation and progression to rupture. J Neuroinflammation (2014) 1.15
Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2+). Am J Physiol Endocrinol Metab (2002) 1.14
Pitx2 is functionally important in the early stages of vascular smooth muscle cell differentiation. J Cell Biol (2008) 1.14
Smooth muscle alpha-actin gene requires two E-boxes for proper expression in vivo and is a target of class I basic helix-loop-helix proteins. Circ Res (2003) 1.13
Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol (2012) 1.12
Delayed goblet cell hyperplasia, acetylcholine receptor expression, and worm expulsion in SMC-specific IL-4Ralpha-deficient mice. PLoS Pathog (2007) 1.12
PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns. Am J Physiol Heart Circ Physiol (2008) 1.12
Exercise training prevents Ca2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic yucatan swine. J Appl Physiol (1985) (2006) 1.11
Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. J Thorac Cardiovasc Surg (2011) 1.11
Myocardin is differentially required for the development of smooth muscle cells and cardiomyocytes. Am J Physiol Heart Circ Physiol (2011) 1.10
PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins. Mol Cell Biol (2005) 1.09
Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol (2009) 1.08
Stem cells and their derivatives can bypass the requirement of myocardin for smooth muscle gene expression. Dev Biol (2005) 1.08
[Effect of food thickener on disintegration and dissolution of magnesium oxide tablets]. Yakugaku Zasshi (2015) 1.08
Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine. Comp Med (2003) 1.07
Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. Biochem Biophys Res Commun (2011) 1.07
Vascular smooth muscle cells in cerebral aneurysm pathogenesis. Transl Stroke Res (2013) 1.06
The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin. J Biol Chem (2009) 1.06
Angiotensin II, oxidative stress and skeletal muscle wasting. Am J Med Sci (2011) 1.06
Smooth and cardiac muscle-selective knock-out of Kruppel-like factor 4 causes postnatal death and growth retardation. J Biol Chem (2010) 1.06
Effects of Food Thickeners on the Inhibitory Effect of Voglibose Oral-disintegrating Tablets on Post-prandial Elevation of Blood Sugar Levels. Yakugaku Zasshi (2016) 1.06
TNF-α induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology. J Cereb Blood Flow Metab (2013) 1.05
Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1. Cell Signal (2011) 1.05